DopamineReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D2Dopamine AgonistsDopamine AntagonistsReceptors, Dopamine D3BenzazepinesReceptors, Dopamine D5Dopamine AgentsDopamine Plasma Membrane Transport ProteinsQuinpiroleSpiperoneCorpus StriatumApomorphineDopamine Uptake InhibitorsSalicylamidesSulpirideHaloperidolRacloprideReceptors, Dopamine D4ErgolinesDopamine beta-Hydroxylase2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineFlupenthixolNucleus AccumbensNeostriatumButaclamolCocaineAmphetamineLevodopaDomperidoneDopamine and cAMP-Regulated Phosphoprotein 32BromocriptineRats, Sprague-DawleyCaudate NucleusOxidopamineHomovanillic AcidBehavior, AnimalSubstantia NigraTyrosine 3-MonooxygenaseMSH Release-Inhibiting HormoneDopaminergic NeuronsMotor ActivityNeuronsPergolideVentral Tegmental AreaMicrodialysisPutamenBrainMesencephalonDose-Response Relationship, DrugCatalepsyAntipsychotic AgentsRadioligand AssayDyskinesia, Drug-Inducedalpha-MethyltyrosineStereotyped BehaviorRewardDihydroxyphenylalanineHydroxydopaminesTetrahydronaphthalenesMethamphetaminePyrrolidinesNomifensineBasal GangliaAntiparkinson AgentsPimozidePrefrontal CortexFenoldopamVesicular Monoamine Transport ProteinsParkinsonian DisordersClozapineYawningReserpineCentral Nervous System StimulantsBrain ChemistrySelf AdministrationLisurideSerotoninFluphenazineTropanesConditioning, OperantDextroamphetamineSynaptic TransmissionNorepinephrinePhenanthridines1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDrug Partial AgonismCyclic AMPDrug InteractionsParkinson Disease, SecondaryCatecholaminesAnalysis of VarianceBiogenic MonoaminesNerve Tissue ProteinsLimbic SystemCocaine-Related DisordersGroomingRats, Wistar